John B. Harlow, Jr.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John B. Harlow, Jr.
John B. Harlow, Jr. is recorded as COO at Larimar Therapeutics, Inc. (LRMR). Larimar Therapeutics, Inc. reported in an 8-K filed September 29, 2026 that John B. Harlow, Jr. was appointed President and Chief Operating Officer, effective September 29, 2026.
“The Board of Directors (the “Board”) of Larimar Therapeutics, Inc. (the “Company”) appointed John B. Harlow, Jr. as the Company’s President and Chief Operating Officer pursuant to the terms of an employment agreement with Mr. Harlow (the “Employment Agreement”), effective as of September 29, 2026 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-29–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Larimar Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Carole Ben-Maimon CEO, Board Member
- Carole S. Ben-Maimon CEO, Board Member
- Joseph Truitt Chairman, Board Member
- Michael Celano CFO
- Frank E. Thomas Board Member
- Jeffrey W. Sherman, MD, FACP Board Member
- Jonathan Leff Board Member
- Thomas E. Hamilton Board Member
- Thomas Edward Hamilton Board Member
- Thomas O. Daniel Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.